Biotech News

Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook

Sotera Health (SHC)Sotera HealthCompany update

2025 net revenues increased 5.7% to $1.164 billion, compared to 2024, or 5.2% on a constant currency basis 2025 net income increased to $78 million or $0.27 per diluted share, compared to net income of $44 million, or $0.16 per diluted share, in 2024 2025 Adjusted EBITDA (1) increased 8.2% to $594

Related news

Sotera Health

Healthcare Sterilization Infrastructure Sotera Health provides sterilization, laboratory testing and advisory services that support the safety and regulatory compliance of medical devices, pharmaceuticals and other healthcare products. Its businesses operate at critical points between product manufacturing and release to...

Recent company news

Stock data

Close
19.57 USD
Market cap
4.28B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States